News + Filings Holdings
|
Deep Track Capital, LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Jazz Pharmaceuticals plc
| JAZZ | Common | 1,250,000 | 376,447 | 154,962,500,000 | 15,796,772,000 | 7.17 | 1.95 |
Hist
| 06/30/2023 |
INSMED Inc
| INSM | Common | 6,500,000 | 2,235,708 | 137,150,000,000 | 51,949,446,000 | 6.35 | 4.76 |
Hist
| 06/30/2023 |
IONIS PHARMACEUTICALS INC
| IONS | Common | 2,834,069 | 1,628,296 | 116,281,851,000 | 70,739,805,000 | 5.38 | 1.98 |
Hist
| 06/30/2023 |
Travere Therapeutics, Inc.
| TVTX | Common | 7,370,000 | 2,788,000 | 113,203,200,000 | 16,843,740,000 | 5.24 | 11.38 |
Hist
| 06/30/2023 |
Immunovant, Inc.
| | Common | 5,421,330 | -4,288,670 | 102,842,630,000 | -69,509,870,000 | 4.76 | 4.16 |
Hist
| 06/30/2023 |
Intra-Cellular Therapies, Inc.
| ITCI | Common | 1,548,252 | 1,548,252 | 98,035,317,000 | 98,035,317,000 | 4.54 | |
Hist
| 06/30/2023 |
ALKERMES INC
| ALKS | COM | 3,000,000 | 3,000,000 | 93,900,000,000 | 93,900,000,000 | 4.35 | |
Hist
| 06/30/2023 |
SpringWorks Therapeutics, Inc.
| SWTX | Common | 3,546,435 | 436,549 | 92,987,526,000 | 12,099,391,000 | 4.30 | 5.67 |
Hist
| 06/30/2023 |
DYNAVAX TECHNOLOGIES CORP
| DVAX | Common | 6,557,816 | 4,229,865 | 84,726,983,000 | 59,957,584,000 | 3.92 | 5.14 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 24,170,966 | 16,756,273 | 77,588,801,000 | 59,645,244,000 | 3.59 | 4.75 |
Hist
| 06/30/2023 |
PLIANT THERAPEUTICS, INC.
| PLRX | Common | 4,050,000 | 2,317,054 | 73,386,000,000 | 39,888,154,000 | 3.40 | 6.85 |
Hist
| 06/30/2023 |
BICYCLE THERAPEUTICS plc
| BCYC | SPONSORED ADS | 2,819,045 | 0 | 71,942,028,000 | -11,501,704,000 | 3.33 | |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 3,187,415 | 0 | 67,381,953,000 | -15,905,201,000 | 3.12 | |
Hist
| 06/30/2023 |
Guardant Health, Inc.
| GH | Common | 1,500,000 | 1,500,000 | 53,700,000,000 | 53,700,000,000 | 2.49 | 1.46 |
Hist
| 06/30/2023 |
4D Molecular Therapeutics, Inc.
| FDMT | Common | 2,778,107 | 121,206 | 50,200,393,000 | -8,809,378,000 | 2.32 | 8.35 |
Hist
| 06/30/2023 |
AGENUS INC
| AGEN | Common Stock | 30,000,000 | 3,000,000 | 48,000,000,000 | -16,800,000,000 | 2.22 | 8.60 |
Hist
| 06/30/2023 |
Beam Therapeutics Inc.
| BEAM | Common | 1,317,316 | 150,843 | 42,061,900,000 | -3,558,859,000 | 1.95 | 1.73 |
Hist
| 06/30/2023 |
Autolus Therapeutics plc
| AUTL | Common | 15,000,000 | 0 | 35,700,000,000 | 7,200,000,000 | 1.65 | 8.67 |
Hist
| 06/30/2023 |
Intellia Therapeutics, Inc.
| NTLA | Common | 835,446 | 135,446 | 34,069,488,000 | 9,646,488,000 | 1.58 | 0.95 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 1,279,502 | -491,652 | 30,439,353,000 | -21,296,055,000 | 1.41 | 2.97 |
Hist
| 06/30/2023 |
Nurix Therapeutics, Inc.
| NRIX | Common | 2,997,830 | 731,261 | 29,948,322,000 | 5,061,394,000 | 1.39 | 6.22 |
Hist
| 06/30/2023 |
Repare Therapeutics Inc.
| RPTX | Common | 2,727,606 | 0 | 28,858,071,000 | -11,265,013,000 | 1.34 | 6.48 |
Hist
| 06/30/2023 |
Editas Medicine, Inc.
| EDIT | COM | 3,453,744 | 3,453,744 | 28,424,313,000 | 28,424,313,000 | 1.32 | 5.01 |
Hist
| 06/30/2023 |
Dyne Therapeutics, Inc.
| DYN | Common | 2,499,912 | -184,288 | 28,124,010,000 | -2,985,868,000 | 1.30 | 4.29 |
Hist
| 06/30/2023 |
ANI PHARMACEUTICALS INC
| ANIP | Common | 514,021 | 514,021 | 27,669,750,000 | 27,669,750,000 | 1.28 | 2.86 |
Hist
| 06/30/2023 |
Axsome Therapeutics, Inc.
| AXSM | COM | 384,200 | 384,200 | 27,608,612,000 | 27,608,612,000 | 1.28 | |
Hist
| 06/30/2023 |
POINT Biopharma Global Inc.
| PNT | Common | 2,781,565 | 2,781,565 | 25,200,979,000 | 25,200,979,000 | 1.17 | 2.63 |
Hist
| 06/30/2023 |
Edgewise Therapeutics, Inc.
| EWTX | Common | 2,750,000 | -624,394 | 21,312,500,000 | -8,854,582,000 | 0.99 | 4.35 |
Hist
| 06/30/2023 |
Zura Bio Ltd
| ZURA | Common | 2,523,000 | 2,523,000 | 20,688,600,000 | 20,688,600,000 | 0.96 | 9.33 |
Hist
| 06/30/2023 |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
| PACB | Common | 1,451,201 | 1,451,201 | 19,300,973,000 | 19,300,973,000 | 0.89 | 0.58 |
Hist
| 06/30/2023 |
Acumen Pharmaceuticals, Inc.
| ABOS | Common | 3,916,361 | -35,639 | 18,837,696,000 | -2,503,104,000 | 0.87 | 9.55 |
Hist
| 06/30/2023 |
RAPT Therapeutics, Inc.
| RAPT | Common | 1,004,561 | -300,379 | 18,785,291,000 | -7,052,521,000 | 0.87 | 2.92 |
Hist
| 06/30/2023 |
PROTHENA CORP PUBLIC LTD CO
| PRTA | PUT | 250,000 | 250,000 | 17,070,000,000 | 17,070,000,000 | 0.79 | |
Hist
| 06/30/2023 |
Vigil Neuroscience, Inc.
| VIGL | Common | 1,773,409 | -330,765 | 16,670,045,000 | -9,632,130,000 | 0.77 | 4.97 |
Hist
| 06/30/2023 |
Astria Therapeutics, Inc.
| ATXS | Common | 1,697,415 | -119,116 | 14,139,467,000 | -12,908,680,000 | 0.65 | 6.06 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|